Market niche RP Returns operates in reverse distribution and disposal of pharmaceuticals, licensed by the DEA and State Board of Pharmacy. This indicates a tightly regulated process with potential cross-sell opportunities to drug manufacturers, wholesalers, hospitals, and pharmacies requiring compliant disposal, credit recovery, and recall management.

Regulatory trust With DEA and State Board of Pharmacy licensing, RP Returns can position itself as a compliant remediation partner for customers facing serialization, recall, or end-of-life inventory challenges, offering risk-reduction and audit-ready disposal workflows for healthcare providers.

Client base Current customers include manufacturers, distributors, hospitals, pharmacies, and clinical practices across the US and Puerto Rico. This broad but healthcare-focused base suggests cross-selling opportunities to similar entities in need of credit recovery and compliant disposal services.

Tech-enabled ops Utilizing cloud and data analytics stack (Snowplow, AWS, Oracle Cloud) and web platforms indicates capability to integrate with customers’ data flows, automate reporting, and provide traceable, auditable disposal and credit processes—a selling point for data-driven procurement and compliance teams.

Growth levers Revenue size indicates potential for scale through expanded service lines (credit recovery, recall management, hazardous waste disposal, and OTC/non-controlled handling) and geographic expansion, appealing to enterprise buyers seeking end-to-end reverse distribution solutions.